Geoffrey Martha - 25 Aug 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
CEO, Director
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
25 Aug 2021
Net transactions value
-$820,646
Form type
4
Filing time
26 Aug 2021, 19:26:21 UTC
Previous filing
04 Aug 2021
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $81,929 +1,481 +1.5% $55.32 97,317 25 Aug 2021 Direct F1
transaction MDT Ordinary Shares Sale $196,484 -1,481 -1.5% $132.67 95,836 25 Aug 2021 Direct F1
transaction MDT Ordinary Shares Options Exercise $633,876 +10,100 +11% $62.76 105,936 25 Aug 2021 Direct F1
transaction MDT Ordinary Shares Sale $1,339,967 -10,100 -9.5% $132.67 95,836 25 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1,481 -100% $0.000000* 0 25 Aug 2021 Ordinary Shares 1,481 $55.32 Direct F1, F2, F3
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -10,100 -37% $0.000000 17,519 25 Aug 2021 Ordinary Shares 10,100 $62.76 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
F3 This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
F4 This option to purchase 1,594 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,594 Medtronic Inc. common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
F5 This option to purchase 27,619 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of 27,619 Medtronic common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.